Clinical Trial Update: Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexlansoprazole-based triple therapy to rabeprazole-based triple therapy for Helicobacter pylori infection; the study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AcipHex (rabeprazole) (rabeprazole)
• Dexilant (dexlansoprazole) (dexlansoprazole)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED